Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF)/Permanent Study

NCT00431834 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT00431834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00431834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF)/Permanent Study
Lead sponsor
Medtronic Cardiovascular
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
August 31, 2011
Enrollment
75 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation